Cedilla Therapeutics
Cedilla Therapeutics

Cedilla Therapeutics Information

Contact top employees from Cedilla Therapeutics

Summary

Cedilla Therapeutics is a private company that has been in the industry for 7 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the President & CEO is occupied by Alexandra Glucksmann. Its headquarters is located at Cambridge, Massachusetts, USA. The number of employees ranges from 25 to 100. The annual revenue of Cedilla Therapeutics varies between 100K and 5.0M. Total funding of the company - $113.8M. To connect with Cedilla Therapeutics employee register on SignalHire.

Organization Website

cedillatx.com

Social Links

linkedIn

Phone Number

617-281-5658

Industries

Headquarters Location

245 First Street, Cambridge, Massachusetts, 02142 US

Employees Size

10-50 employees

Specialties

Biotechnology, Protein, Life Sciences, Third Rock Ventures, Oncology, Science, Medicine, Team

SIC Code

2834

DMA Code

Greater Boston

Founded

2018

Estimated Annual Revenue

$100K - 5.0M

Operating Status

Independent Company

Competitors

Founded
Type
Employees
Revenue
Funding
2010Privately
Held
25 - 100 7.1M $158M
2013Public
Company
1.0K - 5.0K 106M $1.5B
2017Privately
Held
25 - 100 2.5M $210.5M
2018Privately
Held
25 - 100 2M $109M

Employees Turnover 3 quarter 2025

Length of Employment
arrow
Employee tenure at Cedilla Therapeutics shows a diverse range of experience levels:
8% for 1–2 years46% for 3–4 years31% for 5–7 years15% for 8–10 years
Contact top employees from Cedilla Therapeutics
Sarah Giaccai
Senior Manager, People Operations
View
Benjamin Xu
Information Technology Engineer
View

FAQ

Cedilla Therapeutics operates in the Biotech industries. More details can be found on the official website: cedillatx.com.
The headquarters of Cedilla Therapeutics are located in Cambridge, United States.
The current CEO of Cedilla Therapeutics is Alexandra Glucksmann
You can contact Cedilla Therapeutics by phone at 617-281-5658.
Cedilla Therapeutics currently employs 10-50 people.
Cedilla Therapeutics's revenue is approximately 2.5M.
Well-known competitors of Cedilla Therapeutics include Apexigen, Juno Therapeutics, Inc., VelosBio Inc. and Dyno Therapeutics.
BACK TO TOP